Aktieanalyser

Nedan återfinns aktieanalytiker som täcker Ascelia Pharma.

Carnegie Investment Bank (tidigare Erik Penser Bank)
Ludvig Svensson
+46 704 962 535
ludvig.svensson@carnegie.se

Redeye
Johan Unnerus
+46 724 023 385
johan.unnerus@redeye.se

Nedan återfinns aktieanalyser på Ascelia Pharma:

250211 – Carnegie Access

241108 – Redeye update

241108 – Penser Access by Carnegie

240916 – Penser Access by Carnegie

240904 – Redeye update

240819 – HC Andersen Capital

240819 – Redeye update

240520 – Redeye update

240502 – Redeye update

240212 – Penser Access by Carnegie (in Swedish)

230918 – Redeye update

230821 – Erik Penser update (in Swedish)

230809- Redeye update

220516 – Analysguiden (in Swedish)

211220 – Erik Penser Bank equity research initiation of coverage

211111 – Analysguiden

210520 – Analysguiden (in Swedish)

201023 – Equity Research Redeye (in Swedish)

200526 – Analysguiden (in Swedish)

200325 – Equity Research Redeye (in Swedish)

200305 – Analysguiden-Carlsquare

200220 – Equity Research Vator Securities

200220 – Analysguiden-Carlsquare

190619 – Aktiespararnas aktieanalys (Analysguiden)

191014 – Redeye aktieanalys

190528 – Aktiespararnas aktieanalys (Analysguiden)

190521 – Equity Research Edison Group

190425 – Equity Research Vator Securities